scjtuu'-jr 6-7 - minutes or meeting 
2 
Others in attendance for all or part of the meeting were ; 
Dr. John Allans, Pharmaceutical Manufacturers Association; Dr. Richard 
Atfamson, Office of .Science and Technology Policy; Dr. E. A. Agostine, 
Pfizer, Incorporated; Dr. David Anderson, Genex; Dr. Rosanne Apfeldorf, 
Occupational Safety and Health Administration; Dr. N. H. Baltz, Eli 
LilLy and Company; Dr. Q. Bond, National Academy of Sciences; Dr. J. Paul 
Burnett, Eli Lilly and Company; Dr. Dennis Chamot, American Federation 
of Labor-COngress of Industrial Organizations; Mr. Leslie Dach, Environmental 
Defense Ftind; Dr. D. W. Dennen, Eli Lilly and Company; Dr. M. Dennis, 
Natural Resources Defense Council; Mr. Torn Edwards, Blue Sheet; Dr. Sybil 
Francis, Natural Resources Defense Council; Dr. William Gibb, Staff, United 
States Senate Commerce Committee; Dr. Clarence Grogan, Department of 
Agci culture; Dr. Lowell Harmison, Office of the Assistant Secretary 
for Health; Dr. Zsolt Harsanyi, Office of Technology Assessment; Dr. Paul 
Huang, Abbott Research Laboratories; Dr. Evelyn Hurlburt, Johns Hopkins 
School of Hygiene; Dr. Dorothy Jessup, Department of Agriculture; Dr. I. S. 
Johnson, Eli Lilly and Company; Dr. Robert W. M. Kinney, Environmental 
Control Incorporated; Dr. Gretchen Kolsrud, Office of Technology Assessment; 
Mr. Louis La Marca, Blue Sheet; Dr. David Logan, Occupational Safety 
and Health Administration; Dr. Janes McCullough, Library of Congress; 
Dr. James Purch, Upjohn Company; Dr. Michael Ross, Genentech, Incorporated; 
Dr. Anne Schauer, Unitsd States Department of Agriculture; Dr. Nelson 
Schneider, E. F. Hutton; Mr. H. M. Schmeck, New York Times; Di . Brian 
Sheehan, Genentech, Incorporated; Dr. Vincent Simmon, Genex; Dr. Louis 
Sles n, Natural Resources Defense Council; Mr. Dan Smith, Peoples 
Business Commission; Dr. Richard Snyder, Department of the Interior; 
Dr. Stephanie Soucek, National Institute for Occupational Safety and 
Health; Dr. J. R. Swarz, Staff, United States Senate; Dr. David West, 
National Institute for Occupational Safety and Health; Dr. Roy Widdus, 
National Academy of Sciences; Dr. Susan Wright, University of Michigan; 
and Dr. w. P. Young, Eli Lilly and Company. 
I. CAvLL TO ORDER AND OPENING REMARKS 
Dr. Setlow, chairperson, called the meeting to order and introduced the new 
RAC meibers. 
II. MINUTES OF MAY 21-23 1978 MEETING 
The RAC reviewed and approved with several minor modifications the Minutes 
of the May 21-23, 1979, meeting by a vote of 12 to 0. 
III. PROCEDURES FOR PROTECTION OF PROPRIETARY INFORMATION 
The RAC reviewed a document (696) prepared by NIH staff, entitled "Guide 
for the Control of Privileged Recombinant DNA Information. " This document 
establishes minimum requirements to control and protect documents that 
contain privileged recombinant DNA information. Dr. Gottesman said that 
[ 151 ] 
